Sanjay Rajagopalan Selected Research

Particulate Matter

2/2024	Air pollution exposure and cardiometabolic risk.
12/2023	Alzheimer`s disease mortality in the United States: Cross-sectional analysis of county-level socio-environmental factors.
7/2023	Particulate air pollution exaggerates diet-induced insulin resistance through NLRP3 inflammasome in mice.
1/2023	Burden of cardiovascular disease attributable to particulate matter pollution in the eastern Mediterranean region: analysis of the 1990-2019 global burden of disease.
1/2021	Ambient Air Pollution and Atherosclerosis: Insights Into Dose, Time, and Mechanisms.
12/2020	Personal-Level Protective Actions Against Particulate Matter Air Pollution Exposure: A Scientific Statement From the American Heart Association.
11/2020	Exposure to Air Pollution Disrupts Circadian Rhythm through Alterations in Chromatin Dynamics.
1/2020	Associations between particulate matter air pollution, presence and progression of subclinical coronary and carotid atherosclerosis: A systematic review.
11/2019	Air pollution-derived particulate matter dysregulates hepatic Krebs cycle, glucose and lipid metabolism in mice.
1/2019	Alpha2B-Adrenergic Receptor Overexpression in the Brain Potentiate Air Pollution-induced Behavior and Blood Pressure Changes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sanjay Rajagopalan Research Topics

Disease

41	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 09/2003
41	Inflammation (Inflammations) 11/2023 - 09/2003
32	Atherosclerosis 01/2024 - 05/2002
23	Insulin Resistance 07/2023 - 09/2007
22	Type 2 Diabetes Mellitus (MODY) 04/2024 - 02/2009
20	Heart Failure 03/2024 - 03/2003
14	Hypertension (High Blood Pressure) 03/2024 - 08/2003
12	Chronic Renal Insufficiency 03/2024 - 11/2003
12	Obesity 03/2024 - 09/2007
11	Myocardial Infarction 05/2023 - 09/2003
10	Peripheral Arterial Disease 01/2020 - 09/2002
9	Stroke (Strokes) 01/2023 - 09/2009
8	Atherosclerotic Plaque (Atheroma) 03/2024 - 11/2009
8	Weight Loss (Weight Reduction) 01/2022 - 09/2007
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2024 - 08/2003
7	Fibrosis (Cirrhosis) 01/2024 - 09/2003
6	Neoplasms (Cancer) 01/2024 - 11/2015
6	Diabetes Mellitus 01/2020 - 11/2011
5	Ischemia 12/2012 - 02/2002
4	Body Weight (Weight, Body) 03/2024 - 01/2010
4	Cardiomyopathies (Cardiomyopathy) 01/2024 - 01/2006
4	Atrial Fibrillation 12/2021 - 07/2009
4	Intermittent Claudication 10/2011 - 10/2003
3	Coronary Disease (Coronary Heart Disease) 04/2024 - 05/2003
3	Prediabetic State (Prediabetes) 03/2024 - 01/2018
3	Coronary Artery Disease (Coronary Atherosclerosis) 03/2023 - 05/2004
3	Infarction (Infarctions) 01/2023 - 07/2004
3	Arteritis 01/2023 - 01/2020
3	Hyperglycemia 01/2022 - 10/2014
3	Overweight 01/2019 - 04/2004
2	Carotid Artery Diseases 03/2024 - 01/2020
2	COVID-19 01/2024 - 11/2022
2	Heart Diseases (Heart Disease) 01/2024 - 01/2023
2	Glucose Intolerance 11/2023 - 01/2013
2	Hypercholesterolemia 06/2023 - 01/2023
2	Vascular Diseases (Vascular Disease) 01/2022 - 04/2008
2	Lung Diseases (Lung Disease) 01/2020 - 11/2019
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 10/2017
2	Dyslipidemias (Dyslipidemia) 01/2018 - 04/2008

Drug/Important Bio-Agent (IBA)

41	Particulate MatterIBA 02/2024 - 06/2004
17	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 05/2011
14	CalciumIBA 03/2024 - 08/2005
12	LipidsIBA 11/2023 - 01/2006
11	Biomarkers (Surrogate Marker)IBA 10/2023 - 10/2005
10	Insulin (Novolin)FDA Link 04/2024 - 01/2010
9	CholesterolIBA 04/2024 - 10/2014
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2023 - 10/2005
9	IncretinsIBA 01/2018 - 01/2013
7	GadoliniumIBA 01/2024 - 11/2009
7	Air Pollutants (Pollutants, Air)IBA 01/2019 - 02/2009
6	Triglycerides (Triacylglycerol)IBA 04/2024 - 08/2003
6	omega-Chloroacetophenone (Mace)IBA 01/2024 - 01/2020
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2010 - 01/2003
5	oxidized low density lipoproteinIBA 06/2023 - 01/2006
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2004
5	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 09/2017 - 05/2002
4	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2024 - 03/2016
4	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2023 - 11/2011
4	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 01/2022
4	Lipoproteins (Lipoprotein)IBA 01/2022 - 07/2007
4	Apolipoproteins E (ApoE)IBA 01/2022 - 12/2005
4	Messenger RNA (mRNA)IBA 01/2022 - 12/2009
4	C-Reactive ProteinIBA 12/2021 - 07/2007
4	AntioxidantsIBA 01/2018 - 10/2002
4	OzoneIBA 01/2016 - 08/2013
4	Peptides (Polypeptides)IBA 01/2015 - 03/2011
3	Sodium-Glucose Transport ProteinsIBA 04/2024 - 01/2022
3	LDL Lipoproteins (beta Lipoproteins)IBA 03/2024 - 01/2006
3	Environmental Pollutants (Pollutants, Environmental)IBA 01/2024 - 11/2015
3	EnzymesIBA 10/2023 - 06/2010
3	CytokinesIBA 01/2023 - 06/2015
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2022 - 02/2013
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 11/2002
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2017 - 01/2014
3	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2016 - 01/2010
3	LeptinIBA 01/2016 - 09/2007
3	Thioctic Acid (Lipoic Acid)IBA 01/2015 - 01/2010
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2013 - 03/2003
3	Angiotensin IIIBA 03/2011 - 07/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2008 - 05/2003
3	Mineralocorticoid Receptor AntagonistsIBA 03/2006 - 05/2002
3	Nitroglycerin (Dynamite)FDA LinkGeneric 11/2005 - 02/2002
3	AldosteroneIBA 07/2004 - 03/2003
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2024 - 11/2022
2	LDL CholesterolIBA 06/2023 - 01/2023
2	Uric Acid (Urate)IBA 01/2022 - 01/2022
2	ApolipoproteinsIBA 12/2021 - 12/2009
2	CreatinineIBA 05/2021 - 03/2003
2	TroponinIBA 01/2020 - 12/2019
2	MicroRNAs (MicroRNA)IBA 12/2018 - 01/2016
2	AerosolsIBA 01/2018 - 10/2014
2	N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamideIBA 01/2018 - 10/2014
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 11/2003
2	Spironolactone (Aldactone)FDA LinkGeneric 09/2017 - 03/2006

Therapy/Procedure

24	Therapeutics 04/2024 - 11/2002
5	Renal Dialysis (Hemodialysis) 12/2013 - 10/2006
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
3	Precision Medicine 01/2019 - 04/2012
2	Ambulatory Care (Outpatient Care) 04/2024 - 01/2024
2	Secondary Prevention 06/2017 - 04/2008